Presenilin 2 Activators

Presenilin 2 Activators are a group of chemical compounds which have distinct influences on biochemical or cellular pathways that ultimately lead to the functional activation of Presenilin 2. These activators either increase intracellular cAMP levels, activate protein kinases like PKA and PKC, or inhibit phosphatases like PP2A, all of which are steps leading to the enhancement of Presenilin 2 activity. For example, Forskolin, db-cAMP, Isoproterenol, Sp-cAMP, Rolipram, Cilostamide, and Ro 20-1724 all increase cAMP levels within the cell, either by directly activating adenylyl cyclase, mimicking cAMP, or inhibiting cAMP-degrading phosphodiesterases. This increase in cAMP activates PKA, which phosphorylates and activates Presenilin 2. On the other hand, two compounds, PMA and Staurosporine, act by activating PKC, another kinase known to phosphorylate and activate Presenilin 2. Finally, EGCG, Okadaic Acid, and Calyculin A indirectly enhance Presenilin 2 activity by inhibiting PP2A, a phosphatasethat dephosphorylates Presenilin 2. By inhibiting this phosphatase, these compounds maintain higher levels of phosphorylated and active Presenilin 2. Thus, these activators, although different in their mechanisms of action, ultimately lead to the same outcome - the activation of Presenilin 2.

Several Presenilin 2 activators operate by influencing intracellular cAMP levels. Increased cAMP leads to the activation of Protein Kinase A (PKA), which can phosphorylate Presenilin 2, thereby enhancing its function. Forskolin, for instance, is an activator of adenylyl cyclase, leading to increased cAMP production. Dibutyryl-cAMP (db-cAMP) and Sp-cAMP are cAMP analogues that increase intracellular cAMP levels. Beta-adrenergic agonist Isoproterenol also increases cAMP levels. Rolipram, Cilostamide, and Ro 20-1724 are phosphodiesterase inhibitors that prevent cAMP degradation, thereby increasing its intracellular levels. Another set of activators work via protein phosphorylation. PMA and Staurosporine are potent activators of Protein Kinase C (PKC), which phosphorylates Presenilin 2, leading to its activation. Conversely, EGCG, Okadaic Acid, and Calyculin A are inhibitors of protein phosphatase 2A (PP2A), a protein that dephosphorylates Presenilin 2. By inhibiting PP2A, these compounds ensure higher levels of phosphorylated and active Presenilin 2. Hence, through diverse mechanisms, these chemical compounds effectively enhance the functional activity of Presenilin 2.